Publications by authors named "R Scuccimarri"
Kawasaki disease in Kenya and review of the African literature.
Pediatr Rheumatol Online J
April 2024
Background: Kawasaki disease has been described across the globe, although publications from Africa are limited. To our knowledge, there are no publications on Kawasaki disease from Kenya, which triggered this report.
Methods: A retrospective cross-sectional study was undertaken to identify in-patients with a discharge diagnosis of Kawasaki disease, over 2 different 5-year periods, at two pediatric hospitals in Nairobi, Kenya.
Background: Direct comparisons of paediatric hospitalizations for acute coronavirus disease 2019 (COVID-19) and multisystem inflammatory syndrome in children (MIS-C) can inform health system planning. We describe the absolute and relative hospital burden of acute paediatric COVID-19 and MIS-C in Canada.
Methods: This national prospective study was conducted via the Canadian Paediatric Surveillance Program from March 2020-May 2021.
Objective: Using Canadian Alliance of Pediatric Rheumatology Investigators (CAPRI) juvenile idiopathic arthritis (JIA) registry data, we describe (1) clinical characteristics of patients with JIA transitioning to adult care, (2) prevalence of disease-related damage and complications, and (3) changes in disease activity during the final year prior to transfer.
Methods: Registry participants who turned 17 years between February 2017 and November 2021 were included. Clinical characteristics and patient-reported outcomes (PROs) at the last recorded pediatric rheumatology visit, and changes observed in the year prior to that visit were analyzed.
Objective: To assess changes in juvenile idiopathic arthritis (JIA) treatments and outcomes in Canada, comparing 2005-2010 and 2017-2021 inception cohorts.
Methods: Patients enrolled within three months of diagnosis in the Research in Arthritis in Canadian Children Emphasizing Outcomes (ReACCh-Out) and the Canadian Alliance of Pediatric Rheumatology Investigators Registry (CAPRI) cohorts were included. Cumulative incidences of drug starts and outcome attainment within 70 weeks of diagnosis were compared with Kaplan-Meier survival analysis and multivariable Cox regression.
Article Synopsis
- The study explored factors affecting spinal reshaping in children with leukemia and other conditions who were treated with glucocorticoids (GC), analyzing 79 kids over 6 years.
- Results showed that 82.3% of the children had complete vertebral body reshaping within 1.3 years, with more success in the thoracic region than the lumbar region.
- Increased GC exposure, a higher spinal deformity index (SDI), and more severe or additional vertebral fractures negatively impacted the likelihood of reshaping, indicating these children could be at risk for lasting spinal issues.